PLYMOUTH MEETING, Pa. (AP) — PLYMOUTH MEETING, Pa. (AP) — Inovio Pharmaceuticals Inc. (INO) on Thursday reported a loss of $33.9 million in its third quarter.
The Plymouth Meeting, Pennsylvania-based company said it had a loss of 13 cents per share. Losses, adjusted for asset impairment costs, came to 9 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The drugmaker posted revenue of $388,400 in the period. Its adjusted revenue was $388,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INO at https://www.zacks.com/ap/INO